TrialJournal of thrombosis and thrombolysis2019

Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study.

Seth Woodruff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.